PAX Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$380K Sell
4,380
-274
-6% -$26.2K 0.06% 142
2025
Q4
$447K Sell
4,654
-354
-7% -$34.4K 0.08% 138
2025
Q3
$477K Sell
5,008
-610
-11% -$56.1K 0.09% 144
2025
Q2
$490K Sell
5,618
-2,433
-30% -$206K 0.09% 146
2025
Q1
$723K Buy
8,051
+523
+7% +$46.8K 0.13% 131
2024
Q4
$601K Buy
7,528
+252
+3% +$21.8K 0.11% 152
2024
Q3
$655K Buy
7,276
+49
+0.7% +$4.12K 0.12% 149
2024
Q2
$569K Sell
7,227
-181
-2% -$14.8K 0.11% 158
2024
Q1
$646K Sell
7,408
-25
-0.3% -$2.13K 0.13% 154
2023
Q4
$641K Buy
7,433
+951
+15% +$72.5K 0.13% 152
2023
Q3
$508K Buy
6,482
+44
+0.7% +$3.68K 0.12% 153
2023
Q2
$567K Buy
6,438
+61
+1% +$5.25K 0.13% 147
2023
Q1
$514K Sell
6,377
-97
-1% -$7.91K 0.12% 143
2022
Q4
$503K Sell
6,474
-10
-0.2% -$810 0.13% 132
2022
Q3
$524K Buy
6,484
+137
+2% +$12.3K 0.13% 128
2022
Q2
$570K Sell
6,347
-642
-9% -$65K 0.14% 118
2022
Q1
$775K Buy
6,989
+84
+1% +$8.87K 0.18% 98
2021
Q4
$714K Buy
6,905
+488
+8% +$56.5K 0.16% 116
2021
Q3
$804K Sell
6,417
-37
-0.6% -$4.79K 0.2% 82
2021
Q2
$801K Buy
6,454
+276
+4% +$34.7K 0.2% 80
2021
Q1
$730K Sell
6,178
-467
-7% -$54.7K 0.21% 73
2020
Q4
$778K Sell
6,645
-2,202
-25% -$242K 0.24% 43
2020
Q3
$919K Buy
8,847
+4,311
+95% +$433K 0.32% 42
2020
Q2
$416K Buy
4,536
+463
+11% +$44.4K 0.16% 86
2020
Q1
$404K Buy
4,073
+1,367
+51% +$145K 0.17% 71
2019
Q4
$305K Buy
+2,706
New +$297K 0.13% 92

Other funds holding MDT

PAX Financial Group's MDT Position: Q1 2026 in Review

PAX Financial Group reduced its Medtronic (MDT) stake by 5.9% in Q1 2026, selling an estimated $26.2K and leaving 4,380 shares worth $380K. The position accounts for 0.06% of the portfolio, ranked #142.

PAX Financial Group first reported a position in MDT in Q4 2019 and has held it in 26 quarters since. The position peaked at $919K in Q3 2020. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • PAX Financial Group held 4,380 shares of Medtronic worth $380K as of Q1 2026.
  • PAX Financial Group sold 274 Medtronic shares in Q1 2026, an estimated $26.2K.
  • Medtronic made up 0.06% of PAX Financial Group's portfolio in Q1 2026, its #142 holding.
  • PAX Financial Group first reported a position in Medtronic in Q4 2019 and has held it in 26 quarters since.
  • PAX Financial Group's Medtronic position peaked at $919K in Q3 2020.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on PAX Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.